Home  »  Stock   »  Why is Comera Life Sciences Holdings Inc. (CMRA) d...

Why is Comera Life Sciences Holdings Inc. (CMRA) down -70.21% from the day 1 this year?

Let’s start up with the current stock price of Comera Life Sciences Holdings Inc. (CMRA), which is $2.98 to be very precise. The Stock rose vividly during the last session to $3.885 after opening rate of $3.86 while the lowest price it went was recorded $2.85 before closing at $3.89.Recently in News on June 22, 2022, Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform. Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, expanded its patent portfolio with the issuance of U.S. Patent No. 11,357,857 (the ‘857 patent), which provides Comera exclusive rights pertaining to certain excipients in its SQore™ platform as viscosity-lowering agents to significantly optimize filtration efficiency of protein solutions during the biologics manufacturing process. The ‘857 patent reflects a significant addition to Comera’s current intellectual property portfolio and expands the potential commercial applications of SQore, broadening patent protections beyond use in therapeutic antibody formulations to include manufacturing process enhancement. You can read further details here

Comera Life Sciences Holdings Inc. had a pretty Dodgy run when it comes to the market performance.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Comera Life Sciences Holdings Inc. (CMRA) full year performance was -70.21%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Comera Life Sciences Holdings Inc. shares are logging -80.52% during the 52-week period from high price, and 168.47% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.11 and $15.30.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1021234 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Comera Life Sciences Holdings Inc. (CMRA) recorded performance in the market was -70.58%, having the revenues showcasing -70.93% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 45.86M.

The Analysts eye on Comera Life Sciences Holdings Inc. (CMRA)

During the last month, 0 analysts gave the Comera Life Sciences Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CMRA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Comera Life Sciences Holdings Inc. (CMRA)

In the last 20 days, the company’s Stochastic %K was 65.56% and its Stochastic %D was recorded 72.18%.

Considering, the past performance of Comera Life Sciences Holdings Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -70.58%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -70.58%, alongside a downfall of -70.21% for the period of the last 12 months. The shares 8.36% in the 7-day charts and went down by 10.78% in the period of the last 30 days. Common stock shares were lifted by -70.93% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]